Anebulo Pharmaceuticals Ownership | Who Owns Anebulo Pharmaceuticals?


OverviewForecastFinancialsChart

Anebulo Pharmaceuticals Ownership Summary


Anebulo Pharmaceuticals is owned by 82.41% institutional investors, 40.54% insiders. 22nw, lp is the largest institutional shareholder, holding 56.42% of ANEB shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 0.29% of its assets in Anebulo Pharmaceuticals shares.

ANEB Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAnebulo Pharmaceuticals82.41%40.54%-22.94%
SectorHealthcare Stocks 479.67%11.03%-390.70%
IndustryBiotech Stocks 295.80%10.97%-206.77%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
22nw, lp15.47M56.42%$22.27M
Nantahala capital management3.04M11.08%$4.37M
Mangrove partners2.53M9.21%$3.64M
Morgan stanley399.22K1.54%$1.09M
Lvw advisors349.62K1.28%$503.45K
Vanguard group154.04K0.59%$258.78K
Ikarian capital157.72K0.58%$227.12K
Geode capital management91.34K0.35%$153.50K
Boothbay fund management18.84K0.07%$27.12K
Blackrock funding, inc. /de17.21K0.06%$24.79K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
22nw, lp15.47M14.03%$22.27M
Mangrove partners2.53M0.39%$3.64M
Nantahala capital management3.04M0.17%$4.37M
Lvw advisors349.62K0.05%$503.45K
Ikarian capital157.72K0.04%$227.12K
Boothbay fund management18.84K0.00%$27.12K
Morgan stanley399.22K0.00%$1.09M
Tower research capital llc (trc)3.33K0.00%$5.59K
Wells fargo & company/mn---
Hrt financial lp---

Top Buyers

HolderShares% AssetsChange
Blackrock funding, inc. /de17.21K-11.45K
Geode capital management91.34K-3.55K
Tower research capital llc (trc)3.33K0.00%632.00
Bank of america corp /de/65.00-65.00
Ameritas advisory services10.00-10.00

Top Sellers

HolderShares% AssetsChange
King luther capital management---59.66K
Susquehanna group, llp---25.25K
Hrt financial lp---23.16K
Ubs group25.00--738.00
Blackrock3.76K--288.00

New Positions

HolderShares% AssetsChangeValue
Ameritas advisory services10.00-10.00$14.00

Sold Out

HolderChange
Jpmorgan chase-8.00
Wells fargo & company/mn-62.00
Hrt financial lp-23.16K
Susquehanna group, llp-25.25K
King luther capital management-59.66K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202518-22,591,946-0.12%822.72%8-11.11%3-25.00%
Mar 31, 20251820.00%22,618,2420.21%550.73%912.50%4-
Dec 31, 20241515.38%22,570,347207.34%8710.85%860.00%433.33%
Sep 30, 2024138.33%7,343,7340.49%283.57%525.00%350.00%
Jun 30, 202412-14.29%7,307,7780.02%283.51%4-33.33%2-33.33%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF121.00K0.29%-
Vanguard Total Stock Mkt Idx Inv118.41K0.29%-2.59K
Fidelity Extended Market Index96.47K0.23%-252.00
Vanguard Institutional Extnd Mkt Idx Tr92.03K0.22%-2.92K
Fidelity Total Market Index48.16K0.12%-
Fidelity Series Total Market Index39.48K0.10%-
iShares Micro-Cap ETF16.42K0.04%-
Spartan Extended Market Index Pool F11.88K0.03%-
Spartan Extended Market Index Pool E10.74K0.03%6.32K
Fidelity Nasdaq Composite Index7.79K0.02%-

Recent Insider Transactions


DateNameRoleActivityValue
Dec 23, 2024English Aron R. Buy$10.00M
Dec 17, 2021English Aron R. Buy$2.63K
Dec 14, 2021English Aron R. Buy$2.43K
Dec 03, 2021English Aron R. Buy$26.68K
Dec 02, 2021English Aron R. Buy$73.33K

Insider Transactions Trends


DateBuySell
2024 Q4--
2024 Q2--
2024 Q1--
2023 Q4--
2023 Q3--

ANEB Ownership FAQ


Who Owns Anebulo Pharmaceuticals?

Anebulo Pharmaceuticals shareholders are primarily institutional investors at 82.41%, followed by 40.54% insiders and -22.95% retail investors. The average institutional ownership in Anebulo Pharmaceuticals's industry, Biotech Stocks , is 295.80%, which Anebulo Pharmaceuticals falls below.

Who owns the most shares of Anebulo Pharmaceuticals?

Anebulo Pharmaceuticals’s largest shareholders are 22nw, lp (15.47M shares, 56.42%), Nantahala capital management (3.04M shares, 11.08%), and Mangrove partners (2.53M shares, 9.21%). Together, they hold 76.71% of Anebulo Pharmaceuticals’s total shares outstanding.

Does Blackrock own Anebulo Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Anebulo Pharmaceuticals.

Who is Anebulo Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

22nw, lp is Anebulo Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 14.03% of its assets in 15.47M Anebulo Pharmaceuticals shares, valued at 22.27M$.

Who is the top mutual fund holder of Anebulo Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Anebulo Pharmaceuticals shares, with 0.29% of its total shares outstanding invested in 121K Anebulo Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools